Faculty

Institution

Unit

Venue

Tulio Rodriguez, MD

Rosalind Franklin University of Medicine and Science

Affiliations

Chicago Medical School

Clinical Sciences

Medical Education

School Of Chicago Medical

College of Health Professions

Department Of Biomedical Sciences

School Of Chicago Medical

Department Of Clinical Sciences

Department Of Emergency Medicine

Department Of Foundational Sciences And Humanities

Department Of Medicine

Clinical Sciences

Internal Medicine

Rosalind Franklin University of Medicine and Science

NoneTulio Rodriguez, Md is currently serving as a Chicago Medical School faculty at Rosalind Franklin University of Medicine And Science.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Tulio Rodriguez, MD

Rosalind Franklin University of Medicine and Science

You can click a keyword to filter the displayed items

hematology medicine cell transplantation bone marrow transplantation clinical transplantation stem cell transplantation oncology immunology transplantation medicine organ transplantation hematological malignancies pharmacology radiation oncology regenerative medicine leukemia cell therapy pharmacotherapy lymphoid neoplasia stem cells cellular therapy haematopoiesis clinical trials cancer treatment clinical research medicinal research graft survival multiple myeloma experimental medicine cancer care laboratory medicine transplantation proceeding malignant blood disorders liver transplantation clinical immunology cell replacement therapies cord blood myeloid neoplasia conditioning regimen clinical evidence transplant infectious diseases cancer management transplant surgery novel therapies therapeutic efficacy acute medicine vomiting associated preventive medicine respiratory medicine dermatological treatment tolerance induction disease prevention blood cells experimental dermatology clinical dermatology cutaneous biology kidney transplantation immunomodulation viral diagnostics viral persistence case series cohort studies case studies disease progression allogeneic stem-cell transplants maribavir prophylaxis cytomegalovirus disease randomised trial multi-organ failure severe veno-occlusive disease randomized trial stem cell transplant graft-versus-host disease prevention high-risk hct primary refractory favourable results chemotherapy mobilization pathology therapeutic targets medical history autoimmunity individualized medicine translational research cancer immunotherapy immunotherapy scleroderma cancer research jama oncology cancer cells translational medicine medical education autoimmune diseases cancer letter pediatric transplantation internal medicine

Notable Scholarly Works

Notable Federal Grants

Collaborators

Bcma-Targeting Bite Molecule Amg 420 in Relapsed or Refractory Multiple Myeloma: A Phase 1B Open-Label Expansion Study. Leukemia & lymphoma/Leukemia and lymphoma (2025)

immunologyhematological malignanciesrefractory multiple myelomamyeloid neoplasiacancer researchtherapeutic targetsphase 1boncogenesopen-label expansion studycellular therapycell biology

Early Safety Results of P-Bcma-Allo1, a Fully Allogeneic Chimeric Antigen Receptor T-Cell (Car-T), in Patients With Relapsed / Refractory Multiple Myeloma (Rrmm). Blood (2023)

Bhagirathbhai DholariaMehmet H. KocogluAndrew KinAdam S. AschAravind RamakrishnanCarlos BachierTulio E. RodriguezLeyla ShuneKatherine McArthurJoanne McCaigueSamuel DePrimoChris MartinSabrina HaagMaggie ZhangHamid NaminiEllen ChristieRajesh BelaniStacey A CranertJulia CoronellaDevon J ShedlockCaitlin L. Costello

immunologyhematological malignanciesmedicineclinical transplantationpharmacologyleukemialaboratory medicinehematologyclinical immunologycancer researchcancer managementclinical trialsblood cellsoncologyclinical researchmedicinal researchcancer treatmentcellular therapy

Long Term Disease Free Survival and Survival of Patients With Relapsed Hodgkin's Lymphoma Treated With Autologous Stem Cell Transplantation. Blood (2023)

medicineleukemiacell therapyhematologyradiation oncologylymphoid neoplasialymphoma treatedoncologybone marrow transplantationcell transplantationrelapsed hodgkinclinical transplantationstem cell transplantation

PB2346: Zuma-24: A Phase 2, Open-Label, Multicenter Study of Axicabtagene Ciloleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma Given With Corticosteroids in the Outpatient Setting. HemaSphere (2023)

Lori LeslieMichael TeesIan W. FlinnTulio RodriguezJohn H. BairdAbhinav DeolMonica MeadCarlos BachierAaron P. RapoportBrian MccluneDaanish HodaMiguel-Angel PeralesYan ZhengSimone FilostoMadison Davis1Harry MiaoJenny J. KimOlalekan O. Oluwole

immunologymulticenter studymedicinepharmacologyaxicabtagene ciloleucelhematologylymphoid neoplasiaoncologycarceral setting

Zuma‐24: A Phase 2, Open‐Label Study of Axicabtagene Ciloleucel in Patients With Relapsed/Refractory Large B‐Cell Lymphoma Given Outpatient With Corticosteroids. Hematological Oncology (2023)

L. LeslieM. TeesI. W. FlinnT. E. RodriguezJ. H. BairdA. DeolM. MeadC. BachierA. P. RapoportB. McCluneD. HodaM. PeralesY. ZhengS. FilostoM. DavisH. MiaoJ. J. KimO. O. Oluwole

immunologyopen-label studyaxicabtagene ciloleucelhematologylymphoid neoplasiaoncology

Characteristics of Patients With Hematologic Malignancies Without Seroconversion Post-Covid19 Third Vaccine Dosing (3V): Real-World Data From Large Midwestern Healthcare System.. Journal of Clinical Oncology (2022)

vaccinescommunicable diseasesmedicinepublic health preparednessvaccine safetyhematologycovid-19medical virologyepidemiologyhematologic malignanciesvaccine efficacyreal-world datahospital infectionsclinical epidemiologyinfectious diseases

All-071: A Phase 4 Study to Evaluate Outpatient Blinatumomab in Patients With Minimal/Measurable Residual Disease (Mrd) Positivity (+) of B-Cell Precursor Acute Lymphoblastic Leukemia (Bcp-All). Clinical Lymphoma Myeloma & Leukemia (2021)

Sharif S. KhanShahram MoriDeepa JeyakumarMichael Kenneth KengHemant S. MurthyMichal Bar-NatanKrishna GundaboluKristen O’DwyerTulio RodriguezAnthony Selwyn SteinCaspian OliaiChristopher McCannFaraz ZamanGerhard ZugmaierPaul GordonTimothy S. Pardee

hematological malignanciesmyeloid neoplasiaemergency medicinemixed-phenotype acute leukemiacancer carehematologyretrospective cohort studiesleukemiamultiple sclerosisoutpatient blinatumomabdiagnosissurgical oncologylymphoid neoplasiacancer immunotherapyimmunologyradiologythoracic oncologycancer discoveryoncology

Persistent Sars-Cov-2 Infectivity Greater Than 50 Days in a Case Series of Allogeneic Peripheral Blood Stem Cell Transplant Recipients. Current Problems in Cancer Case Reports (2021)

immunologymedicinesars-cov-2viral persistencecovid-19medical virologytransplant infectious diseasespersistent sars-cov-2 infectivityvirologybone marrow transplantationcell transplantationinfectious diseasescase seriesclinical transplantationstem cell transplantationviral diagnostics

Busulfan, Melphalan, and Bortezomib Compared to Melphalan as a High Dose Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow Up of a Novel High Dose Regimen. Leukemia & lymphoma/Leukemia and lymphoma (2020)

Patrick HagenAnita D'SouzaParameswaran HariOmar DavilaMei-Jie ZhangDavid H. VesoleScott E. SmithTulio E. RodriguezPatrick J. Stiff

immunologyhematological malignanciesleukemiaclinical transplantationhematologyhigh dose regimensurgical oncologyurologystem cellsoncologybone marrow transplantationcell transplantationmalignant blood disorderscohort studieslong termmultiple myelomatumor biology

Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and Cibmtr Outcomes. DukeSpace (Duke University) (2020)

hematological malignanciesmedicineleukemiahematologyradiation oncologylymphoid neoplasiacibmtr outcomesoncologybone marrow transplantationcell transplantationetoposide conditioningpharmacokinetics-directed busulfanclinical transplantation

1
2
3
4
5
8
10 / page

Tulio Rodriguez, MD

Rosalind Franklin University of Medicine and Science

Affiliations

Chicago Medical School

Clinical Sciences

Medical Education

School Of Chicago Medical

College of Health Professions

Department Of Biomedical Sciences

School Of Chicago Medical

Department Of Clinical Sciences

Department Of Emergency Medicine

Department Of Foundational Sciences And Humanities

Department Of Medicine

Clinical Sciences

Internal Medicine

Rosalind Franklin University of Medicine and Science

NoneTulio Rodriguez, Md is currently serving as a Chicago Medical School faculty at Rosalind Franklin University of Medicine And Science.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Tulio Rodriguez, MD

Rosalind Franklin University of Medicine and Science

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Bcma-Targeting Bite Molecule Amg 420 in Relapsed or Refractory Multiple Myeloma: A Phase 1B Open-Label Expansion Study. Leukemia & lymphoma/Leukemia and lymphoma (2025)

immunologyhematological malignanciesrefractory multiple myelomamyeloid neoplasiacancer researchtherapeutic targetsphase 1boncogenesopen-label expansion studycellular therapycell biology

Early Safety Results of P-Bcma-Allo1, a Fully Allogeneic Chimeric Antigen Receptor T-Cell (Car-T), in Patients With Relapsed / Refractory Multiple Myeloma (Rrmm). Blood (2023)

Long Term Disease Free Survival and Survival of Patients With Relapsed Hodgkin's Lymphoma Treated With Autologous Stem Cell Transplantation. Blood (2023)

immunologymulticenter studymedicinepharmacologyaxicabtagene ciloleucelhematologylymphoid neoplasiaoncologycarceral setting

Zuma‐24: A Phase 2, Open‐Label Study of Axicabtagene Ciloleucel in Patients With Relapsed/Refractory Large B‐Cell Lymphoma Given Outpatient With Corticosteroids. Hematological Oncology (2023)

L. LeslieM. TeesI. W. FlinnT. E. RodriguezJ. H. BairdA. DeolM. MeadC. BachierA. P. RapoportB. McCluneD. HodaM. PeralesY. ZhengS. FilostoM. DavisH. MiaoJ. J. KimO. O. Oluwole

immunologyopen-label studyaxicabtagene ciloleucelhematologylymphoid neoplasiaoncology

Persistent Sars-Cov-2 Infectivity Greater Than 50 Days in a Case Series of Allogeneic Peripheral Blood Stem Cell Transplant Recipients. Current Problems in Cancer Case Reports (2021)

Patrick HagenAnita D'SouzaParameswaran HariOmar DavilaMei-Jie ZhangDavid H. VesoleScott E. SmithTulio E. RodriguezPatrick J. Stiff

1
2
3
4
5
8
10 / page